Guggenheim CurrencyShares(r) Exchange Traded Products

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Guggenheim CurrencyShares(r) Exchange Traded Products Declare Monthly Distributions

New York, NY, Jan. 2, 2015 (GLOBE NEWSWIRE) -- Guggenheim Investments, the investment management division of Guggenheim Partners, today announced the distribution declarations for the following CurrencyShares ® exchange traded products: CurrencyShares ® Australian Dollar Trust (NYSE: FXA) and CurrencyShares ® Canadian Dollar Trust (NYSE: FXC).

NYSE Ticker Fund Name Declaration Date Ex-dividend Date Record Date Payable Date/Share
Distribution
FXA CurrencyShares Australian Dollar Trust 12.31.2014 1.2.2015 1.6.2015 1.9.2015 $0.13510
FXC CurrencyShares Canadian Dollar Trust 12.31.2014 1.2.2015 1.6.2015 1.9.2015 $0.00881

Distributions are made to shareholders on a pro-rata basis (in accordance with the number of shares that are owned) only in the event that the interest earned by the Trust exceeds the sum of the sponsor's fee for the prior month plus other Trust expenses, if any. There is no guarantee that distributions will be made on a monthly basis.

CurrencyShares ® offer investors and institutions a convenient and cost-effective method of gaining investment benefits similar to that of holding foreign currencies, including potential diversification and hedging benefits. More details about the products are available at www.currencyshares.com .

About Guggenheim Investments

Guggenheim Investments is the global asset management and investment advisory division of Guggenheim Partners, and manages more than $194 billion 1 in assets across fixed income, equity, and alternatives. We focus on the return and risk needs of insurance companies, corporate and public pension funds, sovereign wealth funds, endowments and foundations, consultants, wealth managers, and high-net-worth investors. Our 250+ investment professionals perform rigorous research to understand market trends and identify undervalued opportunities in areas that are often complex and underfollowed. This approach to investment management has enabled us to deliver innovative strategies providing diversification and attractive long-term results.

###

CurrencyShares are subject to risks similar to those of stocks and may not be suitable for all investors. The value of the shares of each CurrencyShares Trust relates directly to the value of the foreign currency held by the particular Trust. This creates a concentration risk associated with fluctuations in the price of the applicable foreign currency. Accordingly, a decline in the price of that currency will have an adverse effect on the value of the shares of the particular CurrencyShares Trust. Factors that may have the effect of causing a decline in the price of a foreign currency include national debt levels and trade deficits, domestic and foreign interest rates, investment and trading activities of institutions and global or regional political, economic or financial events and situations. Investors should consider the investment objectives, risks, charges and expenses of these products carefully before investing. The prospectus pertaining to each product contains this and other information about the product. Please read the applicable prospectus, including the Risk Factors section, carefully before you invest. Shares can be bought and sold through a broker and the purchasers or sellers may have to pay brokerage commissions in connection with the transaction. Investment returns and principal value will fluctuate so that shares may be worth more or less than original cost. Shares may only be redeemed directly from the Trust by Authorized Participants via baskets (as defined in the prospectus). There can be no assurance that an active trading market for the shares will develop or be maintained. The CurrencyShares Trusts are not investment companies registered under the Investment Company Act of 1940. As a result the Trust(s) are not subject to the regulatory requirements of investment companies.

The CurrencyShares® Australian Dollar Trust , CurrencyShares® British Pound Sterling Trust , CurrencyShares® Canadian Dollar Trust , CurrencyShares® Chinese Renminbi Trust , CurrencyShares® Euro Trust , CurrencyShares® Japanese Yen Trust , CurrencyShares® Singapore Dollar Trust ,   CurrencyShares® Swiss Franc Trust and CurrencyShares® Swedish Krona Trust (each a "Trust" and collectively, the "Trusts") has filed a registration statement (including a prospectus) with the SEC for the offerings to which this communication relates. Before you invest in the shares of a Trust, you should read the prospectus in the registration statement and other documents the Trust has filed with the SEC for more complete information about the Trust and its offering. You may get these documents for free by visiting EDGAR on the SEC web site at www.sec.gov . Alternatively, you may click the links above or the Trust will arrange to send you its prospectus if you request it by calling toll-free 800.820.0888.

The CurrencyShares Trusts are distributed by Guggenheim Funds Distributors, LLC. Guggenheim Investments represents the investment management businesses of Guggenheim Partners, LLC ("Guggenheim"), which includes Security Investors, LLC ("SI"). Guggenheim Specialized Products, LLC ("GSP"), the Sponsor for the CurrencyShares Trusts, is a wholly owned subsidiary of SI. Guggenheim Funds Distributors, LLC, is affiliated with Guggenheim, SI and GSP.

Not FDIC Insured - No Bank Guarantee -May Lose Value.

TEMP 13882

1 Guggenheim Investments total asset figure is as of 9.30.2014 and includes $12.141B of leverage for Assets Under Management and $0.465B of leverage for Serviced Assets.  Total assets include assets from Security Investors, LLC, Guggenheim Partners Investment Management, LLC, Guggenheim Funds and its affiliated entities, and some business units including Guggenheim Real Estate, LLC, Guggenheim Aviation, GS GAMMA Advisors, LLC, Guggenheim Partners Europe Limited, Transparent Value Advisors, LLC, and Guggenheim Partners India Management.  Values from some funds are based upon prior periods.

Media Contacts Guggenheim Ivy McLemore 212.518.9859

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lawyers Juggle AI's Promise and Perils in 2026

Updated Category News Views 104

AI's Growing Pains in the Legal Arena Looks like the legal eagles are getting a run for their money with AI entering the courtroom. Bloomberg Law's 2026 AI in Practice report dives deep into this legal labyrinth. You got attorneys leaning on AI to keep the gears turning, but they're also clutching their pearls over potential pitfalls. Trust Issues: Humans vs. Machines The...

Continue Reading
Siemens Set to Acquire Lauterbach in Strategic Move

Updated Category News Views 81

Siemens Seizing New Opportunities with Lauterbach Acquisition Bam! Siemens is on the move, folks, snapping up Lauterbach to bolster its semiconductor design arsenal. Now, if you’ve got your eyes glued to innovation in chip design, like yours truly, then strap in because this merger is more than just a footnote on some dusty tech page. It's a game-changer when it comes...

Continue Reading
Jinko Solar Joins B20 Summit: Energy Forefront Focus

Updated Category News Views 145

Jinko Solar's Invitation to the B20 Summit Never a dull moment in the solar space, especially when Jinko Solar, a big shot in clean energy, jumps into the spotlight at the B20 Summit in the U.S. Awash with high-profile discussions, Jinko's not just chatting—it's the only photovoltaic firm strutting its stuff in D.C. with gutsy calls for energy reform. Key Takeaways from...

Continue Reading
Paulex Bio's Grant Fuels Bold Diabetes Research Push

Updated Category News Views 89

Cracking the Diabetes Code: A New Hope Emerging It ain't every day you hear about a biotech outfit snagging an NIH Fast-Track grant with the potential to upend diabetes treatment, but Paulex Bio's recent score turns heads. Their brainchild, PAL-119, promises to tackle diabetes not by slapping a band-aid on symptoms, but by getting to the rotten core of the disease: the...

Continue Reading
Shukla MD's New Concierge Program Boosts Patient Care

Updated Category News Views 63

Shifting the Healthcare Paradigm Imagine a healthcare world where doctors actually have the time to listen and engage with you beyond just scribbling notes in haste. That's what's brewing over in Westchester, where Dr. Rachana and Dr. Vaishalee Shukla are putting the old-school patient-doctor relationship front and center with their Hybrid Choice concierge program. Run...

Continue Reading
NHTSA, Ad Council Unveil New Anti-Buzzed Driving PSAs

Updated Category News Views 71

Taking Aim at a Deadly Habit Everyone's got that gut feeling when a day-long meeting runs over or you're stuck in traffic — impatience morphed with slow burn menace. Now picture a whole campaign gunning for that vibe but in the hands of the young folks, those from 21 to 34. That's what we're talking about here, with the Ad Council and NHTSA serving up some fresh public...

Continue Reading
Cognizant Boosts Claude AI with 25,000 Pro Workforce

Updated Category News Views 157

Moving AI from Theory to Practice You know, AI isn't about just keeping up with the hype; it's about shoving those algorithms right where they can do the most good—right at the core of business operations. And that’s precisely what Cognizant's cooking up with their fresh-off-the-press Claude Frontier Capability Group. They’ve thrown more than 25,000 pros into the...

Continue Reading
Bandwidth's SI Innovations: A New Dawn or Just Hype?

Updated Category News Views 56

Bandwidth Unleashes Super Intelligence at Reverb Right off the bat, Bandwidth's Reverb showcase was enough to stir up some excitement in the air. The company laid out a feast of technological advancements with their Super Intelligence (SI) innovations that claim to redefine how enterprises communicate. But here's the rub—while these developments sound thrilling, the...

Continue Reading
Parachute Health Urges HME Transformation Through Collaboration

Updated Category News Views 159

The Road to Digital Unity in HME Cranking through the gears of the healthcare industry is no mean feat, but Parachute Health seems ready to throw some fresh oil on the machine. In a landscape riddled with complexities, they're sounding the call for a more unified digital infrastructure in the Home Medical Equipment (HME) sector through their latest white paper. We're...

Continue Reading
What's at Stake: Pearl Diver's Q3 2026 Earnings Call

Updated Category News Views 60

Upcoming Unveiling: Pearl Diver's Latest Financials Heads up, folks. November 16 can't come soon enough for those keeping tabs on Pearl Diver Credit Company Inc. (NYSE: PDCC, PDPA). The bigwigs over there are planning to spill the beans on their third quarter 2026 financial results. They'll kick things off before the market even has its first cup of java on Monday morning...

Continue Reading

Top 5 Most Recently Viewed Articles

Boardwalktech Software to Showcase Innovations at Upcoming Event

Updated Category News Views 161

Boardwalktech Software Demonstrates Commitment to Innovation Boardwalktech Software Corp. (TSXV: BWLK) (OTCQB: BWLKF), recognized as a leader in the Intelligent Information Platform sector, has announced that their CEO and Chairman, Andrew Duncan, is set to present at the highly anticipated Planet MicroCap Showcase. This event, in partnership with MicroCapClub, serves as...

Continue Reading
Sabio Holdings' Creator Television® Earns Top Newcomer Award

Updated Category News Views 136

Sabio Holdings' Creator Television® Triumphs at Industry Awards In an impressive early success, Creator Television®, a project of Sabio Holdings, has clinched the 'Most Significant Newcomer' award at the InteractiveTV Today (ITVT) Awards. This recognition comes as a significant milestone for the company during Creator TV's first six months since launch. An Award for...

Continue Reading
Starbucks Corporation Under Investigation by Kahn Swick & Foti

Updated Category News Views 344

Starbucks Corporation Faces Investigation In recent developments, Kahn Swick & Foti, LLC has started an investigation regarding Starbucks Corporation (NASDAQ: SBUX). Led by former Louisiana Attorney General Charles C. Foti, Jr., this inquiry raises important questions about the company and its executives. Financial Performance Raises Red Flags Starbucks' recent financial...

Continue Reading
Innovative Nitric Oxide Therapy Shows Promise in Cancer Treatment

Updated Category News Views 213

Exploring the Efficacy of LV UNO Therapy in Cancer Treatment Beyond Cancer, Ltd. has introduced groundbreaking preclinical data showcasing the benefits of Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) therapy. This therapy, when combined with immune checkpoint inhibitors, demonstrates significant potential for enhancing patient outcomes in cancer treatments....

Continue Reading
Wabash Partners with Decisiv to Enhance Service Management

Updated Category News Views 305

Wabash and Decisiv Forge a New Partnership Wabash, a leading provider of innovative supply chain solutions, has formed a strategic partnership with Decisiv to enhance service management capabilities within its dealer network. This collaboration aims to streamline service event management and improve uptime for Wabash customers. Decisiv's Impact on Service Management The...

Continue Reading